Company page

Evommune, Inc.

Evommune, Inc. is a public company trading under the ticker EVMN in the American market. With a market capitalization of approximately $769.4 million, the company is focused on developing innovative solutions in its sector. Evommune aims to address significant challenges and improve outcomes through its research and development efforts.